Home/Filings/4/0001596783-21-000092
4//SEC Filing

Flynn Karen 4

Accession 0001596783-21-000092

CIK 0001596783other

Filed

Jul 27, 8:00 PM ET

Accepted

Jul 28, 4:26 PM ET

Size

7.4 KB

Accession

0001596783-21-000092

Insider Transaction Report

Form 4
Period: 2021-07-26
Flynn Karen
Pres. Biologics & CCO
Transactions
  • Award

    Common Stock

    2021-07-26+1,15135,695 total
  • Award

    Options to purchase Common Stock

    2021-07-26+5,9535,953 total
    Exercise: $113.00Exp: 2031-07-26Common Stock (5,953 underlying)
Footnotes (4)
  • [F1]Restricted stock units (RSUs) received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur three (3) years from the date of award.
  • [F2]Includes restricted stock units.
  • [F3]Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan.
  • [F4]The options vest and become exercisable in four equal annual installments beginning on July 26, 2022.

Issuer

Catalent, Inc.

CIK 0001596783

Entity typeother

Related Parties

1
  • filerCIK 0001553599

Filing Metadata

Form type
4
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 4:26 PM ET
Size
7.4 KB